Moderna Inc.

Moderna Inc. is a biotechnology company focused on the development and commercialization of messenger RNA (mRNA) therapeutics and vaccines. The company's primary function is to harness the potential of mRNA to create innovative treatments for a diverse range of diseases. Moderna's pipeline includes vaccine products targeting infectious diseases, cancer immunotherapies, and rare genetic disorders. Among its most notable achievements is the rapid development and global distribution of its mRNA-based COVID-19 vaccine, which played a significant role in addressing the global pandemic. Moderna's pioneering work in mRNA technology positions it at the forefront of biomedicine, impacting sectors such as public health, pharmaceuticals, and biotechnology research. Moderna's contributions underscore its vital role in the advancement of new medical technologies and treatments, reflecting its broad significance in the life sciences market.